Conference Coverage

VIDEO: Ask epilepsy patients about opioid use


 

AT THE ANNUAL MEETING OF THE AMERICAN EPILEPSY SOCIETY

References

SEATTLE – Epilepsy patients were significantly more likely to use opioid analgesics than were matched controls in a review of 2012 Accordant Health Services claims data.

Investigators matched 10,217 patients with epilepsy to 20,542 without epilepsy, based on gender, age, and insurance type. Cancer patients were among those excluded from the study. Based on prescriptions that were filled at least once, analgesic opioids were used by 26% of epilepsy patients versus 18% of controls (P < 0.001).

There was a significantly higher percentage of pain conditions in the epilepsy group, but diversion or other factors could also be at play, lead investigator Dr. Andrew Wilner, a neurologist with Angels Neurological Centers in Abington, Mass., explained at the annual meeting of the American Epilepsy Society.

The investigation is on-going. In the meantime, he said it’s a good idea to ask epilepsy patients about opioid use.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

aotto@frontlinemedcom.com

Recommended Reading

Group issues recommendations for genetic susceptibility testing for carbamazepine skin reactions
MDedge Psychiatry
Evidence-Based Apps: Is it possible to diagnose epileptic seizure digitally?
MDedge Psychiatry
Drugs approved in 2013
MDedge Psychiatry
Comorbidities in migraine should guide treatment course
MDedge Psychiatry
CBT-informed psychotherapy benefits patients with psychogenic nonepileptic seizures
MDedge Psychiatry
Transition is difficult for young adults with epilepsy treated at pediatric tertiary care centers
MDedge Psychiatry
Memory problems more common in psychogenic nonepileptic seizures plus PTSD
MDedge Psychiatry
Pediatric psychogenic seizures linked to anxiety, depression
MDedge Psychiatry
Pediatric epilepsy linked to Axis I psychiatric disorders
MDedge Psychiatry
FDA issues new pregnancy/lactation drug label standards
MDedge Psychiatry